Citadel Advisors’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$504K Sell
152,156
-307,394
-67% -$1.02M ﹤0.01% 4053
2025
Q1
$1.33M Buy
459,550
+77,872
+20% +$226K ﹤0.01% 2970
2024
Q4
$1.36M Sell
381,678
-490,155
-56% -$1.74M ﹤0.01% 2997
2024
Q3
$4.34M Buy
871,833
+704,020
+420% +$3.51M ﹤0.01% 1883
2024
Q2
$436K Sell
167,813
-56,460
-25% -$147K ﹤0.01% 3921
2024
Q1
$955K Buy
224,273
+56,456
+34% +$241K ﹤0.01% 3239
2023
Q4
$339K Buy
167,817
+165,112
+6,104% +$334K ﹤0.01% 4120
2023
Q3
$4.14K Sell
2,705
-582
-18% -$891 ﹤0.01% 5545
2023
Q2
$5.42K Buy
+3,287
New +$5.42K ﹤0.01% 5450
2023
Q1
Sell
-2,910
Closed -$2.63K 5894
2022
Q4
$2.63K Sell
2,910
-15,153
-84% -$13.7K ﹤0.01% 5862
2022
Q3
$21K Sell
18,063
-53,932
-75% -$62.7K ﹤0.01% 5523
2022
Q2
$46K Buy
71,995
+35,205
+96% +$22.5K ﹤0.01% 5526
2022
Q1
$96K Sell
36,790
-61,078
-62% -$159K ﹤0.01% 5671
2021
Q4
$381K Buy
97,868
+56,157
+135% +$219K ﹤0.01% 4872
2021
Q3
$182K Buy
+41,711
New +$182K ﹤0.01% 5488
2021
Q2
Sell
-75,463
Closed -$392K 6378
2021
Q1
$392K Buy
75,463
+51,209
+211% +$266K ﹤0.01% 4788
2020
Q4
$130K Sell
24,254
-31,738
-57% -$170K ﹤0.01% 4620
2020
Q3
$272K Buy
55,992
+29,765
+113% +$145K ﹤0.01% 3904
2020
Q2
$127K Buy
26,227
+15,605
+147% +$75.6K ﹤0.01% 4196
2020
Q1
$23K Buy
+10,622
New +$23K ﹤0.01% 4642
2018
Q4
Sell
-25,780
Closed -$451K 4478
2018
Q3
$451K Buy
+25,780
New +$451K ﹤0.01% 3224